Cited by

• Dental risk factors for osteonecrosis of the jaws: a CONDOR case-control study.

  Barasch A, Cunha-Cruz J, Curro F, DeRouen T, Gilbert GH, Hujoel P, Safford MM, Vena DA, Voinea-Griffin AE, Wu H; CONDOR Collaborative Group. Barasch A, et al. Clin Oral Investig. 2013 Nov;17(8):1839-45. doi: 10.1007/s00784-012-0880-4. Epub 2012 Dec 2. Clin Oral Investig. 2013. PMID: 23212125 Free PMC article.
• Interventions for managing medication-related osteonecrosis of the jaw.

  Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O. Beth-Tasdogan NH, et al. Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2022 Jul 12;7:CD012432. doi: 10.1002/14651858.CD012432.pub3. PMID: 28983908 Free PMC article. Updated.
• A systematic review of bisphosphonate osteonecrosis (BON) in cancer.

  Migliorati CA, Woo SB, Hewson I, Barasch A, Elting LS, Spijkervet FK, Brennan MT; Bisphosphonate Osteonecrosis Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Migliorati CA, et al. Support Care Cancer. 2010 Aug;18(8):1099-106. doi: 10.1007/s00520-010-0882-1. Epub 2010 Apr 22. Support Care Cancer. 2010. PMID: 20411279
• Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review.

  Yamada SI, Kurita H, Kondo E, Suzuki S, Nishimaki F, Yoshimura N, Morioka M, Ishii S, Kamata T. Yamada SI, et al. Clin Oral Investig. 2019 Aug;23(8):3203-3211. doi: 10.1007/s00784-018-2743-0. Epub 2018 Nov 8. Clin Oral Investig. 2019. PMID: 30406491 Review.
• Efficacy of a nonsurgical treatment regimen in patients with bisphosphonate-related osteonecrosis of the jaws in Saudi Arabia.

  Alsehimy MM. Alsehimy MM. SAGE Open Med. 2014 Feb 14;2:2050312114522995. doi: 10.1177/2050312114522995. eCollection 2014. SAGE Open Med. 2014. PMID: 26770707 Free PMC article.